In a new study, researchers looked to identify unique biomarkers and shared microbial mechanisms among different autoimmune ...

Genentech announced positive results from the Phase III study (REGENCY) of Gazyva (Obinutuzumab) for people with active lupus nephritis (LN).

Autoimmune diseases, including systemic lupus erythematosus (SLE), are more common in women than men, and scientists are ...

In a new study, researchers investigated the prevalence of cardiovascular disease events (CVE) in people with systemic lupus ...

UCB and Biogen have announced positive Phase III clinical trial results for PHOENYCS GO study, evaluating dapirolizumab pegol, a new treatment for moderate-to-severe systemic lupus erythematosus (SLE) ...

Cullinan Therapeutics has filed an investigational new drug application with the U.S. Food and Drug Administration (FDA) for CLN-978 for the treatment of systemic lupus erythematosus (SLE).

A recent study found that regularly checking blood levels of hydroxychloroquine (HCQ, known commercially as Plaquenil®) may ...

In a recent study, researchers explored the association between HCQ and the overall risk of CV events in people with SLE.